دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Highlights from the Journal of the European Academy of Dermatology and Venereology in 2022
Johannes Ring
doi : 10.1111/jdv.18764
Fragrances fuelling fibromyalgia? Patch tester's insights into a complex rheumatic disorder
Olivier Aerts
doi : 10.1111/jdv.18722
Paraneoplastic autoimmune multiorgan syndrome (paraneoplastic pemphigus): How and why should we recognize atypical cases early?
Erkan Alpsoy
doi : 10.1111/jdv.18724
Hair and scalp-related disorders are a trending topic in dermatology, with a significant increase in number of consultations in the last decade
Sergio Vano-Galvan
doi : 10.1111/jdv.18723
Pioneers in Dermatology and Venereology: An Interview with Professor Roderick James Hay
Roderick James Hay
doi : 10.1111/jdv.18730
Quality of life measurement in vitiligo. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes with external experts
Pavel V. Chernyshov, Lucia Tomas-Aragones, Liana Manolache, Nives Pustisek, Carmen Maria Salavastru, Servando E. Marron, Anthony Bewley, Ake Svensson, Françoise Poot, Alina Suru, Sam S. Salek, Matthias Augustin, Jacek С. Szepietowski, Dimitra Koumaki, Alexander C. Katoulis, Francesca Sampogna, Damiano Abeni, Dennis Michael Linder, Reinhart Speeckaert, Nanja van Geel, Julien Seneschal, Khaled Ezzedine, Andrew Y. Finlay
doi : 10.1111/jdv.18593
Members of the European Academy of Dermatology and Venereology (EADV) Task Force on Quality of Life (QoL) and Patient Oriented Outcomes reviewed the instruments available for health-related (HR) QoL assessment in vitiligo and together with external vitiligo experts (including representatives of the EADV Vitiligo Task Force) have made practical recommendations concerning the assessment of QoL in vitiligo patients.
Risk of melanoma in congenital melanocytic nevi of all sizes: A systematic review
Camille Scard, Hélène Aubert, Matthieu Wargny, Ludovic Martin, Sebastien Barbarot
doi : 10.1111/jdv.18581
Congenital melanocytic nevi (CMN) are commonly encountered benign skin lesions in newborns. Larger CMN is associated with a higher lifetime risk of developing melanoma.
The role of HPV in keratinocyte skin cancer development: A systematic review
Nicoleta Neagu, Caterina Dianzani, Aldo Venuti, Serena Bonin, Septimiu Voidăzan, Iris Zalaudek, Claudio Conforti
doi : 10.1111/jdv.18548
Keratinocyte skin cancers are the most frequent malignancy, accounting for approximately 30% of all cancers.
Acquired ichthyosis, asteatotic dermatitis or xerosis? An update on pathoetiology and drug-induced associations
Jason S. Park, Amir H. Saeidian, Leila Youssefian, Sylvia Hsu, Hassan Vahidnezhad, Jouni Uitto
doi : 10.1111/jdv.18608
Acquired ichthyosis (AI) is a relatively rare cutaneous entity characterized by transient, generalized scaling and pruritus in the absence of family history of ichthyosis or atopic disease.
Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry
Cristina Muniesa, Fernando Gallardo, Ignacio GarcÃÂa-Doval, M. Teresa Estrach, Andrea Combalia, Mercedes Morillo-Andújar, Fátima De la Cruz-Vicente, Salma Machan, Cristina Moya-MartÃÂnez, Roger Rovira, Blanca Sanchez-Gonzalez, Elvira Acebo, Elena Amutio, Yeray Peñate, Maria del Carmen Losada-Castillo, M. Pilar GarcÃÂa-Muret, Helena Iznardo, Concepción Román-Curto, Javier Cañueto, Ricardo Fernández-de-Misa, ÃÂ�ngeles Flórez, Rosa MarÃÂa Izu, Ignacio Torres-Navarro, Ana Zayas, Gema Pérez-Paredes, Mar Blanes, J. Ignacio Yanguas, Amparo Pérez-Ferriols, Marta Callejas-Charavia, Pablo Luis Ortiz-Romero, Amalia Pérez-Gil, Lucia Prieto-Torres, Eva González-Barca, Octavio Servitje
doi : 10.1111/jdv.18563
Brentuximab vedotin (BV) has been approved for CD30-expressing cutaneous T-cell lymphoma (CTCL) after at least one previous systemic treatment. However, real clinical practice is still limited.
Risk analysis of systemic side effects of tumescent local anaesthesia in the surgical treatment of geriatric and multimorbid patients with skin cancer
Saskia Maria Schnabl, Claus Garbe, Helmut Breuninger, Vincent Walter, Valentin Aebischer, Julia Eckardt, Franziska Carola Ghoreschi, Hans-Martin Häfner, Alexander Scheu
doi : 10.1111/jdv.18588
Due to demographic change and increased UV exposure, the number of dermatosurgical procedures in the elderly is increasing.
Increased risk of suicidality in patients with psoriasis: A Nationwide cohort study in Korea
Sung Min Kim, Juhee Ahn, Young Ah Cho, Jae Young Sung, Chang Yong Kim, Da-Ae Yu, Yang Won Lee, Sungho Won, Yong Beom Choe
doi : 10.1111/jdv.18565
Psoriasis has a devastating psychological impact on patients' quality of life. However, the relationship between suicidality and psoriasis remains unclear.
Real-world effectiveness and safety of tildrakizumab in long-term treatment of plaque psoriasis: Results from the non-interventional, prospective, multicentre study TILOT
Athanasios Tsianakas, Uwe Schwichtenberg, Peter Pierchalla, Torsten Hinz, Sebastian Diemert, Bernhard Korge
doi : 10.1111/jdv.18572
Plaque psoriasis is a chronic inflammatory disorder affecting the skin and impacting quality of life. Tildrakizumab (TIL) is an IL-23 inhibitor licensed for moderate-to-severe plaque psoriasis.
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study�IL PSO (Italian landscape psoriasis)
Alessandra Narcisi, Mario Valenti, Luigi Gargiulo, Luciano Ibba, Fabrizio Amoruso, Giuseppe Argenziano, Federico Bardazzi, Martina Burlando, Carlo Giovanni Carrera, Giovanni Damiani, Paolo Dapavo, Valentina Dini, Chiara Franchi, Giampiero Girolomoni, Claudio Guarneri, Francesco Loconsole, Francesca Sampogna, Massimo Travaglini, Piergiorgio Malagoli, Antonio Costanzo
doi : 10.1111/jdv.18594
Tildrakizumab is a humanized monoclonal antibody that binds selectively the p19 subunit of interleukin-23. It is approved for treatment of moderate–severe chronic plaque psoriasis.
Increased rates of fragrance allergy in fibromyalgia individuals tested with the Swedish baseline patch test series
Magnus Bruze, Katharine Hopkins, Jakob Dahlin, Karin Olsson, Jacqueline Åstrand, Cecilia Svedman, Robert Ofenloch, Annarita Antelmi
doi : 10.1111/jdv.18562
Contact allergy can manifest in a variety of ways clinically. Systemic contact allergy may occasionally present with pain in muscles and joints. Fibromyalgia is a chronic rheumatic disease characterized by pain and with virtually unknown aetiology.
Atopic dermatitis and risk of major neuropsychiatric disorders in children: A population-based cohort study
Joy Wan, Daniel B. Shin, Maha N. Syed, Katrina Abuabara, Adina R. Lemeshow, Joel M. Gelfand
doi : 10.1111/jdv.18564
Paediatric atopic dermatitis (AD) has been linked to neuropsychiatric comorbidities such as depression, anxiety and attention-deficit/hyperactivity disorder (ADHD). However, longitudinal data are limited, and the effect of AD severity on neuropsychiatric outcomes requires further characterization.
Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce
Angela L. Bosma, Annelie H. Musters, Manja Bloem, Louise A. A. Gerbens, Maritza A. Middelkamp-Hup, Eva Haufe, Jochen Schmitt, Sebastien Barbarot, Julien Seneschal, Delphine Staumont-Sallé, Emma K. Johansson, Maria Bradley, Laura B. von Kobyletzki, Ida Vittrup, Iben Frier Ruge, Jacob P. Thyssen, Christian Vestergaard, Marina de Vega, Ignacio GarcÃa-Doval, Andrea Chiricozzi, Luca Stingeni, Piergiacomo Calzavara-Pinton, Michael R. Ardern-Jones, Nick J. Reynolds, Carsten Flohr, Phyllis I. Spuls
doi : 10.1111/jdv.18566
The TREatment of ATopic eczema (TREAT) Registry Taskforce is a collaborative international network of registries collecting data of atopic eczema (AE) patients receiving systemic and phototherapy with the common goal to provide long-term real-world data on the effectiveness, safety and cost-effectiveness of therapies.
Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis
Andrew Blauvelt, Leon Kircik, Kim A. Papp, Eric L. Simpson, Jonathan I. Silverberg, Brian S. Kim, Shawn G. Kwatra, Michael E. Kuligowski, May E. Venturanza, Shaoceng Wei, Jacek C. Szepietowski
doi : 10.1111/jdv.18571
Ruxolitinib cream is a topical formulation of ruxolitinib, a Janus kinase (JAK) 1/JAK2 inhibitor.
Paraneoplastic pemphigus: A detailed case series from the Netherlands revealing atypical cases
Farhat Zaheri, Hendri H. Pas, Jeroen Bremer, Joost M. Meijer, Marieke C. Bolling, Barbara Horvath, Gilles F. H. Diercks
doi : 10.1111/jdv.18557
Paraneoplastic pemphigus (PNP) is an extremely rare life-threatening blistering autoimmune disease that is associated with an underlying neoplasm.
Chronic pruritus in multiple sclerosis and clinical correlates
Giuseppe Ingrasci, Leticia Tornes, Andrew Brown, Silvia Delgado, Jeffrey Hernandez, Qai Ven Yap, Gil Yosipovitch
doi : 10.1111/jdv.18561
To date, little is known about the prevalence of itch in multiple sclerosis (MS) and its characteristics.
Comparison of topical benzyl benzoate vs. oral ivermectin in treating scabies: A randomized study
Damian Meyersburg, Tobias Welponer, Andreas Kaiser, Sylvia Selhofer, Rafaella Tatarski, Alessandra Handisurya, Johannes Wolfgang Bauer
doi : 10.1111/jdv.18573
Scabies is an itchy, parasitic infection of the skin. Recent reports indicate there is a decreasing efficacy of the standard treatment of choice, topical 5% permethrin cream.
Evolution of the facial skin microbiome during puberty in normal and acne skin
Andrea M. Schneider, Zachary T. Nolan, Kalins Banerjee, Allison R. Paine, Zhaoyuan Cong, Samantha L. Gettle, Amy L. Longenecker, Xiang Zhan, George W. Agak, Amanda M. Nelson
doi : 10.1111/jdv.18616
The composition of the skin microbiome varies from infancy to adulthood and becomes most stable in adulthood.
Accuracy and clinical relevance of an automated, algorithm-based analysis of facial signs from selfie images of women in the United States of various ages, ancestries and phototypes: A cross-sectional observational study
Frederic Flament, Ruowei Jiang, Jeff Houghton, Yuze Zhang, Camille Kroely, Nina G. Jablonski, Aurelie Jean, Jeffrey Clarke, Jason Steeg, Cassidy Sehgal, James McParland, Caroline Delaunay, Thierry Passeron
doi : 10.1111/jdv.18541
Real-life validation is necessary to ensure our artificial intelligence (AI) skin diagnostic tool is inclusive across a diverse and representative US population of various ages, ancestries and skin phototypes.
Changing spectrum of hair and scalp disorders over the last decade in a tertiary medical centre
Anna Lyakhovitsky, Ido Tzanani, Sarit Gilboa, Oz Segal, Eran Galili, Sharon Baum, Aviv Barzilai
doi : 10.1111/jdv.18570
Hair- and scalp-related disorders (HSRDs) encompass a wide range of conditions that affect people of all ages.
Burden of caregivers and out-of-pocket expenditures related to epidermolysis bullosa in France
Emmanuelle Bourrat, Charles Taieb, Adrien Marquié, Patricia Causse, Christina Bergqvist, Angelique Sauvestre, Nathalia Bellon
doi : 10.1111/jdv.18554
Inherited epidermolysis bullosa (EB) is a heterogeneous group of genodermatoses characterized by localized or generalized skin and/or mucosal fragility.
New onset pemphigus foliaceus following AstraZeneca COVID-19 vaccination
Mina Almasi-Nasrabadi, Radha S. Ayyalaraju, Ashish Sharma, Somaia Elsheikh, Shanti Ayob
doi : 10.1111/jdv.18484
Association of interstitial granulomatous dermatitis with messenger Rna–1273 Sars-Cov-2 vaccine
Cesare Ariasi, Gabriele Perazzolli, Alessandra Gelmetti, Simonetta Battocchio, Piergiacomo Calzavara-Pinton
doi : 10.1111/jdv.18490
Alopecia areata after COVID-19 infection and vaccination: A cross-sectional analysis
Betty Nguyen, Antonella Tosti
doi : 10.1111/jdv.18491
Safety of the COVID-19 vaccine booster in patients with immunobullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation
Michael Kasperkiewicz, Rebecca Strong, Marc Yale, Patrick Dunn, David T. Woodley
doi : 10.1111/jdv.18493
New-onset vitiligo after COVID-19 mRNA vaccination: A causal association?
Electra Nicolaidou, Charitomeni Vavouli, Ioannis-Alexios Koumprentziotis, Maria Gerochristou, Alexander Stratigos
doi : 10.1111/jdv.18513
Safe delivery of systemic anti-cancer treatment for skin cancers during the COVID-19 pandemic
Maria Jose Monroy-Iglesias, Hajer Hadi, Beth Russell, Charlotte Moss, Lucy Flanders, Saoirse Dolly, Sophie Papa, Mieke Van Hemelrijck
doi : 10.1111/jdv.18514
Rituximab in immunobullous disorders during the COVID-19 pandemic: A systematic review of observational studies
Michael Kasperkiewicz, David T. Woodley
doi : 10.1111/jdv.18538
Reply to A. Ruggiero et al. to our article ‘Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity’
Rafaele Molinier, Anissa Roger, Bastien Genet, Philippe Saiag, Elisa Funck-Brentano
doi : 10.1111/jdv.18542
Effects of COVID-19 pandemic on malignant melanoma diagnosis
Alessia Villani, Massimiliano Scalvenzi, Gabriella Fabbrocini, Luigi Fornaro, Gianluca Guerrasio, Luca Potestio
doi : 10.1111/jdv.18545
Despite the use of ivermectin during the COVID pandemic, scabies keeps playing tricks with us
Juliana Polizel Ocanha-Xavier, José Cândido Caldeira Xavier-Junior
doi : 10.1111/jdv.18547
COVID-19 induced pityriasis rubra pilaris: A superantigenic disease?
Italo Francesco Aromolo, Armando Pisapia, Davide Riva, Francesco Barberi, Angelo Valerio Marzano, Chiara Moltrasio, Maurizio Romagnuolo
doi : 10.1111/jdv.18556
Course and outcome of chilblain-like acral lesions during COVID-19 pandemic
Kristin Blau, Sophia Lehr, Roland Aschoff, Suzan Al Gburi, Normi Brück, Maria Chapsa, Anja Schnabel, Susanne Abraham, Korinna Jöhrens, Stefan Beissert, Claudia Günther
doi : 10.1111/jdv.18582
Anaplastic large cell lymphoma at the SARS-CoV2 vaccine injection site
Laura Revenga-Porcel, Yeray Peñate, Francisco Granados-Pacheco
doi : 10.1111/jdv.18615
Bullous pemphigoid and COVID-19 vaccination: Management and treatment reply to ‘Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: A report and brief literature review’ by Pauluzzi et al.
Fabrizio Martora, Angelo Ruggiero, Teresa Battista, Gabriella Fabbrocini, Matteo Megna
doi : 10.1111/jdv.18503
Comment on ‘Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions’
Giulia Ciccarese, Francesco Broccolo, Aurora Parodi, Francesco Drago
doi : 10.1111/jdv.18498
Authors' reply to comment by Ciccarese et al. regarding ‘Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions’
Esperanza Welsh, Jesus Alberto Cardenas-de la Garza, Elizabeth Brussolo-MarroquÃÂn, Adrian Cuellar-Barboza, Rodolfo Franco-Marquez, Gerardo Ramos-Montañez
doi : 10.1111/jdv.18546
Reply to ‘Nail psoriasis: A rare mRNA COVID-19 vaccine reaction’ by Lamberti A et al.
Angelo Ruggiero, Luca Potestio, Teresa Battista, Gabriella Fabbrocini, Matteo Megna
doi : 10.1111/jdv.18537
Skin reaction after SARS-CoV-2 vaccines Reply to ‘cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience’
Fabrizio Martora, Alessia Villani, Claudio Marasca, Gabriella Fabbrocini, Luca Potestio
doi : 10.1111/jdv.18531
Genetic evidence of a sarcomatoid transformation in Merkel cell carcinoma
Simon Barbieux, Anne Tallet, Christine Collin, Matthias Tallegas, Flore Delalande, Guido Bens, Annie Levy, Athanasios Kalampokas, David Schrama, Roland Houben, Antoine Touzé, Jeremy Garcia, Nicolas Macagno, Romain Appay, Mahtab Samimi, Serge Guyétant, Thibault Kervarrec
doi : 10.1111/jdv.18529
The influence of PRAME immunohistochemistry on the diagnosis, diagnostic confidence and treatment recommendation by dermatopathologists: A single institution prospective survey-based study
Luke T. Dang, Iryna Rybak, Yue Lyu, Thomas Konia, Maxwell A. Fung, Lihong Qi, Maija Kiuru
doi : 10.1111/jdv.18536
Sleep quality is associated with disease severity in adult patients with inflammatory dermatoses
Bruno Halioua, Jonathan Taieb, Anne-Laure Demessant-Flavigny, Delphine Kerob, Sophie Seité, Caroline Le Floc'h, Charles Taieb
doi : 10.1111/jdv.18505
Trisomy 12p mosaicism syndrome in a patient with hypopigmented cutaneous mosaicism and three cell lines in peripheral blood
Saray Porcar Saura, Macarena DÃaz Giménez, Santiago Guillén-Climent, Cristina Villar, Ana Ruiz Quilez, Maria Rosario Abellán Sanchez, Ana Cuesta Peredo, Jose M. MartÃn
doi : 10.1111/jdv.18555
Synchronous melanoma: A multi-centre case series
Anna Wolinska, Marta Costa Blasco, Gregg Murray, Cliona Feighery, Muireann Roche
doi : 10.1111/jdv.18526
The predictive power of FDG-PET imaging with regard to immunotherapy in real-life conditions in advanced melanoma: An exploratory study
Katleen Blanchet, Jean Charles Sebille, Cécile Frenard, Philippe Lecerf, Amir Khammari, Thomas Carlier, Caroline Bodet-Milin, Brigitte Dréno
doi : 10.1111/jdv.18501
Artificial intelligence-based biopsy site recommendation solution for melanoma: A pilot study
Ji Ho Park, Woo Hyup Lee, Jeong Wook Moon, Jee Yun Doh, Yeong Ho Kim, Chul Hwan Bang, Ji Hyun Lee, Young Min Park, Ju Hee Han
doi : 10.1111/jdv.18506
Toxic seaweed dermatitis in New Caledonia: An epidemiological and clinical study of 83 cases
Yves-Marie Ducrot, Olivier P. Thomas, Maël Nicolas, Georges Kakue, Anne Desnues, Claude Payri, Antoine Bertolotti
doi : 10.1111/jdv.18495
Severe atopic dermatitis in a patient with Loeys-Dietz syndrome treated with dupilumab
Spyridon Gkalpakiotis, Tereza Maresova
doi : 10.1111/jdv.18504
Efficacy of N-acetylcysteine in trichotillomania (hair-pulling disorder), skin-picking disorder and onychophagia (compulsive nail-biting)
Nadia Kashetsky, Aaron Wong, Joseph M. Lam, Se Mang Wong, Ilya M. Mukovozov
doi : 10.1111/jdv.18508
The Bork-Baykal phenomenon and umbilical sparing in large and giant congenital melanocytic nevus: A 21-case series
Ethel Nunes de Sousa Fernandes, Rudolf Happle, Bernardo Gontijo, Joao Renato Vianna Gontijo, Flávia Vasques Bittencourt
doi : 10.1111/jdv.18530
Prevalence and predictors of perceived stigmatization in adult patients with moderate-to-severe atopic dermatitis in France
Bruno Halioua, Marie Bastien, Charles Taieb, Claire Thenie, Charlotte Veniard, Margaux Noel, Laurent Misery
doi : 10.1111/jdv.18515
Dermoscopy of nodular scabies: An observational study
Enzo Errichetti, Giuseppe Stinco, Aimilios Lallas
doi : 10.1111/jdv.18585
Post-irradiation Renbok phenomenon in erythema multiforme: Report of a case sparing previously irradiated areas
Marta BertolÃÂn-Colilla, Ferran Olmos-Alpiste, Nuria RodrÃÂguez de Dios, Ramon Maria Pujol
doi : 10.1111/jdv.18532
Brachioradial pruritus successfully treated with intravenous naloxone
Claudia Zeidler, Manuel P. Pereira, Sonja Ständer
doi : 10.1111/jdv.18553
Characterizing and assessing the reliability of TikTok's most viewed alopecia-related videos
Betty Nguyen, Alexandra G. Perez, Natasha A. Mesinkovska, Antonella Tosti
doi : 10.1111/jdv.18500
Accuracy in anatomical location on dermatological surgery: A multi-centre retrospective study
Francisca Donoso, Leonel Hidalgo, Emily A. Cowen, SofÃÂa Villagran, Paula Villablanca, Constanza Del Puerto, Sergio Silva-Valenzuela, Lucas Galimany, Daniela Majerson, Romina Andino, Pablo Uribe, Katherine Droppelmann, Consuelo Cárdenas, ÃÂ�lvaro Abarzúa-Araya, Juan C. Castro-Ayala, Nicholas R. Kurtansky, Allan C. Halpern, Matthew A. Molenda, Veronica Rotemberg, Cristian Navarrete-Dechent
doi : 10.1111/jdv.18499
Super-high magnification dermoscopy can detect Demodex folliculorum
Elisa Cinotti, Martina Bertello, Carolina Donelli, Renato Rossi, Linda Tognetti, Jean Luc Perrot, Pietro Rubegni
doi : 10.1111/jdv.18496
Low-dose oral minoxidil in female patients with lichen planopilaris: Real-life experience
Giuseppe Gallo, Lorenza Burzi, Francesca Torrelli, Pietro Quaglino, Simone Ribero
doi : 10.1111/jdv.18489
A 5-year retrospective cohort study of basal cell carcinomas on the head and neck: Anatomic location as a predictor of subclinical tumour extension
Marcus G. Tan, Ashley M. Yu, Jillian Macdonald
doi : 10.1111/jdv.18524
Treatment of severe compensatory hyperhidrosis with a microwave device
Won Oak Kim
doi : 10.1111/jdv.18519
Successful treatment of pityriasis rubra pilaris with risankizumab, a IL-23/p19 antagonist
Anne-Laure Fouarge, Marie Cuvelier, Charlotte Roquet-Gravy, Laurence de Montjoye, Marie Baeck
doi : 10.1111/jdv.18516
Store and forward Teledermatology for epidermal necrolysis management: Experience of a French reference centre
Laura Giraud-Kerleroux, Saskia Ingen-Housz-Oro, Nicolas De Prost, Narimane Zeghbib, Caroline Fiani, Margaux Mongereau, Charlotte Gary, Gaëlle Hirsch, Camille Hua, Tu-Anh Duong
doi : 10.1111/jdv.18550
Novel splice site mutation at the C-terminal of SPINK5 cause a unique Netherton syndrome phenotype mimicking pustular psoriasis
Shengyuan Hua, Jing Liu, Biqing Fang, Qiufang Qian, Jia Zhang
doi : 10.1111/jdv.18606
Distinct patient characteristics and pathogenesis of fingernail only vs. fingernail and toenail onychomycosis in a retrospective single-centre academic study
Rhiannon C. Miller, Shari R. Lipner
doi : 10.1111/jdv.18552
Eruptive squamous cell carcinomas following an acute skin inflammatory disease: A series of four cases
Parna Moghadam, Florian Herms, Barouyr Baroudjian, Pauline Tetu, Julie Delyon, Fanélie Jouenne, Marie Boisson, Baptiste Louveau, Samia Mourah, Florence Brunet-Possenti, Lucie Duverger, Valérie Gounant, Céleste Lebbé, Nicole Basset-Seguin
doi : 10.1111/jdv.18559
The role of the optical super high magnification dermoscopy (O.S.H.M.D) in the management of melanocytic lesions
Giulia Radi, Renato Rossi, Federico Diotallevi, Melania Giannoni, Elisa Molinelli, Matteo Paolinelli, Gerardo Ferrara, Annamaria Offidani
doi : 10.1111/jdv.18533
The role of topical therapies along the psoriasis patient journey: An overview from the Symposium ‘Tailoring topical psoriasis treatments to patients' needs and expectations’ of the 30th EADV Congress 2021
Andreas Pinter, Peter van de Kerkhof
doi : 10.1111/jdv.18761
This article summarizes a presentation titled ‘The role of topical therapies along the psoriasis patient journey’ held at the Satellite Symposium of the 30th European Academy of Dermatology and Venereology Congress.
Engaging psoriasis patients in adherence and outcomes to topical treatments: A summary from the Symposium ‘Tailoring topical psoriasis treatments to patients' needs and expectations’ of the 30th EADV Congress 2021
Anthony Bewley, Peter van de Kerkhof
doi : 10.1111/jdv.18751
This article is based on a presentation given by authors at the Satellite Symposium titled ‘Tailoring topical psoriasis treatments to patients' needs and expectations’ held during the 30th European Academy of Dermatology and Venereology Congress.
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30th EADV Congress 2021
Andreas Pinter, Linda Stein Gold, Adam Reich, Lawrence J. Green, Morten Praestegaard, Johan Selmer, April W. Armstrong, Anne Danø, Sunil Dhawan, Jordi Galván, Sandra E. Stallknecht, Paw Trebbien, Matthias Augustin
doi : 10.1111/jdv.18755
Four posters about the novel, fixed-dose calcipotriol and betamethasone dipropionate cream (CAL/BDP cream) based on Poly-Aphron Dispersion (PAD) Technology were presented at the 30th European Academy of Dermatology and Venereology (EADV) Congress 2021 and are summarized here.
The role of topical therapies along the psoriasis patient journey: An overview from the Symposium ‘Tailoring topical psoriasis treatments to patients' needs and expectations’ of the 30th EADV Congress 2021
Andreas Pinter, Peter van de Kerkhof
doi : 10.1111/jdv.18761
This article summarizes a presentation titled ‘The role of topical therapies along the psoriasis patient journey’ held at the Satellite Symposium of the 30th European Academy of Dermatology and Venereology Congress.
Engaging psoriasis patients in adherence and outcomes to topical treatments: A summary from the Symposium ‘Tailoring topical psoriasis treatments to patients' needs and expectations’ of the 30th EADV Congress 2021
Anthony Bewley1 | Peter van de Kerkhof 2
doi : 10.1111/jdv.18751
This article is based on a presentation given by authors at the Satellite Symposium titled ‘Tailoring topical psoriasis treatments to patients' needs and expectations’ held during the 30th European Academy of Dermatology and Venereology Congress.
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30th EADV Congress 2021
Andreas Pinter, Linda Stein Gold, Adam Reich, Lawrence J. Green, Morten Praestegaard, Johan Selmer, April W. Armstrong, Anne Danø, Sunil Dhawan, Jordi Galván, Sandra E. Stallknecht, Paw Trebbien, Matthias Augustin
doi : 10.1111/jdv.18755
Four posters about the novel, fixed-dose calcipotriol and betamethasone dipropionate cream (CAL/BDP cream) based on Poly-Aphron Dispersion (PAD) Technology were presented at the 30th European Academy of Dermatology and Venereology (EADV) Congress 2021 and are summarized here.
